Funding: The project was funded by the National Institute of Health Research (NIHR) Health Technology Assessment (HTA) Programme (project number 12/35/38). The Health Services Research Unit is funded by the Chief Scientist Office of the Scottish Government Health and Social Care Directorates. The funders had no role in considering the study design or in the collection, analysis, or interpretation of data; writing the report; or the decision to submit the article for publication. The views expressed herein are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care. Acknowledgments Sponsor representative: Pauline Hyman-Taylor (from February 2019), Natalie McGregor (March 2015 to February 2019), ...
BACKGROUND: Presentation with advanced glaucoma is the major risk factor for lifetime blindness. Eff...
Background: Aim of study was to evaluate the outcomes of surgical intervention in diagnosed primary ...
Funding Information: Declared competing interests of authors: Anthony J King declares receiving hono...
OBJECTIVE: To determine whether primary trabeculectomy or primary medical treatment produces better ...
Funding: The project was funded by the National Institute of Health Research (NIHR) Health Technolog...
The trial is funded by a grant awarded by the Health Technology Assessment (NIHR HTA) programme (pro...
The trial is funded by a grant awarded by the Health Technology Assessment (NIHR HTA) programme (pro...
Funding Nottingham University Hospitals NHS Trust sponsors the trial and provides the necessary tria...
Objective: To determine whether primary trabeculectomy or primary medical treatment produces better ...
Funding: This project was funded by the National Institute for Health Research (NIHR) Health Technol...
Background: Patients diagnosed with advanced primary open-angle glaucoma are at a high risk of lifet...
Background: Presentation with advanced glaucoma is the major risk factor for lifetime blindness. Eff...
Background: Patients diagnosed with advanced primary open-angle glaucoma are at a high risk of lifet...
Background: Patients diagnosed with advanced primary open-angle glaucoma are at a high risk of lifet...
Nottingham University Hospitals NHS Trust sponsored the trial and provided the necessary trial insur...
BACKGROUND: Presentation with advanced glaucoma is the major risk factor for lifetime blindness. Eff...
Background: Aim of study was to evaluate the outcomes of surgical intervention in diagnosed primary ...
Funding Information: Declared competing interests of authors: Anthony J King declares receiving hono...
OBJECTIVE: To determine whether primary trabeculectomy or primary medical treatment produces better ...
Funding: The project was funded by the National Institute of Health Research (NIHR) Health Technolog...
The trial is funded by a grant awarded by the Health Technology Assessment (NIHR HTA) programme (pro...
The trial is funded by a grant awarded by the Health Technology Assessment (NIHR HTA) programme (pro...
Funding Nottingham University Hospitals NHS Trust sponsors the trial and provides the necessary tria...
Objective: To determine whether primary trabeculectomy or primary medical treatment produces better ...
Funding: This project was funded by the National Institute for Health Research (NIHR) Health Technol...
Background: Patients diagnosed with advanced primary open-angle glaucoma are at a high risk of lifet...
Background: Presentation with advanced glaucoma is the major risk factor for lifetime blindness. Eff...
Background: Patients diagnosed with advanced primary open-angle glaucoma are at a high risk of lifet...
Background: Patients diagnosed with advanced primary open-angle glaucoma are at a high risk of lifet...
Nottingham University Hospitals NHS Trust sponsored the trial and provided the necessary trial insur...
BACKGROUND: Presentation with advanced glaucoma is the major risk factor for lifetime blindness. Eff...
Background: Aim of study was to evaluate the outcomes of surgical intervention in diagnosed primary ...
Funding Information: Declared competing interests of authors: Anthony J King declares receiving hono...